HilleVax | 8-K: Current report
HilleVax | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(9.5%),Tang Capital Management, LLC(9.5%), etc.
HilleVax | 8-K: Current report
HilleVax | 8-K: Current report
HilleVax | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Frazier Life Sciences X, L.P.
HilleVax | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Patrick J. Heron(21.4%),James N. Topper(21.3%), etc.
HilleVax | 4: Statement of changes in beneficial ownership of securities-Director Kohli Aditya
HilleVax | EFFECT: Others
HilleVax | 8-K: HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
HilleVax | 10-Q: Quarterly report
HilleVax | CORRESP: CORRESP
HilleVax | 4: Statement of changes in beneficial ownership of securities-Director Kohli Aditya
HilleVax | ARS: Annual Report to Security Holders
HilleVax | DEFA14A: Others
HilleVax | DEF 14A: Definitive information statements
HilleVax | PRE 14A: Preliminary proxy statements relating to merger or acquisition
HilleVax | 4: Statement of changes in beneficial ownership of securities-10% Owner Frazier Life Sciences X, L.P.
HilleVax | 4: Statement of changes in beneficial ownership of securities-Director Kohli Aditya
HilleVax | 4: Statement of changes in beneficial ownership of securities-Officer McLoughlin Sean
HilleVax | UPLOAD: Others
No Data